1,25(OH)2D3
|
1,25-dihydroxyvitamin D3 |
1,25-D-MARRS |
1,25D-membrane-associated rapid response steroid-binding protein |
7-DHC |
7-dehydrocholesterol |
AB |
Antibody |
ABPM |
Ambulatory Blood pressure measurement |
ACE |
Angiotensin converting enzyme |
AE |
Adverse effects |
AH |
Arterial hypertension |
Ang I |
Angiotensin I |
Ang II |
Angiotensin II |
ARB |
Angiotensin receptor blocker |
AT1R |
Angiotensin II type 1 receptor |
B-AR |
Beta-adrenergic receptor |
BARB |
Beta-adrenergic receptor blockers |
C39 |
C. elegans miR-39 |
CCB |
Calcium channel blocker |
CTGF |
Connective Tissue Growth Factor |
CVD |
Cardiovascular disease |
DBP |
Diastolic blood pressure |
EMT |
Epithelial to Mesenchymal Transition |
FGF23 |
Fibroblast growth factor |
FMD |
Flow mediated dilatation |
HR |
Heart rate |
HT |
Hypertension |
ICAM1 |
Intracellular adhesion molecule 1 |
O-LDL |
Oxidized LDL |
Pi
|
Serum inorganic phosphorus |
PKC |
Protein kinase C |
PRA |
Plasma renin activity |
PRC |
Plasma renin concentration |
Pre-D3 |
Pre Vitamin D3 |
PTH |
Parathyroid hormone |
RAAS |
Renin-angiotensin-aldosterone-system |
RXR |
Retinoid X receptor |
SBP |
Systolic blood pressure |
SH |
Secondary hypertension |
SNP |
Single nucleotide polymorphism |
T2DM |
Type 2 diabetes |
VD3 |
Vitamin D3 |
VDBP |
Vitamin D-binding protein |
VDR |
Vitamin D receptor |
VitD |
Vitamin D |